Nombre de documents


CV de Maryse Lapeyre-Mestre

Article dans une revue12 documents

  • Ha Thi Thu Nguyen, Antoine Pariente, Jean-Louis Montastruc, Maryse Lapeyre-Mestre, Vanessa Rousseau, et al.. An original pharmacoepidemiological– pharmacodynamic method: application to antipsychotic-induced movement disorders . British Journal of Clinical Pharmacology Br J Clin Pharmacol, 2016, epub ahead of print. <10.1111/bcp.13145>. <inserm-01406529>
  • Maryse Lapeyre-Mestre. A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia. Drugs and Aging, Adis, 2016, <10.1007/s40266-016-0414-x>. <inserm-01420989>
  • Guillaume Moulis, Haleh Bagheri, Laurent Sailler, Annie-Pierre Jonville-Bera, Emmanuelle Weber, et al.. Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 French PharmacoVigilance assessment.. European Journal of Internal Medicine, Elsevier, 2014, 25 (8), pp.777-80. <10.1016/j.ejim.2014.09.006>. <hal-01078985>
  • Philipe Barreto de Souto, Maryse Lapeyre-Mestre, Bruno Vellas, Yves Rolland. Indicators of influenza and pneumococcal vaccination in French nursing home residents in 2011. Vaccine, Elsevier, 2014, 32, pp.846-851. <hal-01061687>
  • Virginie Gardette, Maryse Lapeyre-Mestre, Antoine Piau, Adeline Gallini, Christelle Cantet, et al.. A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe : Predictors of Discontinuation and Switch in the ICTUS Study.: A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer. CNS Drugs, Springer Verlag, 2014, epub ahead of print. <10.1007/s40263-013-0133-3>. <inserm-00931663>
  • Régis Fuzier, Isabelle Serres, Emmanuelle Guitton, Maryse Lapeyre-Mestre, Jean-Louis Montastruc. Adverse drug reactions to gabapentin and pregabalin : a review of the French pharmacovigilance database.. Drug Safety, Springer Verlag, 2013, 36 (1), pp.55-62. <10.1007/s40264-012-0006-6>. <inserm-00788899>
  • Adeline Gallini, Virginie Gardette, Bruno Vellas, Maryse Lapeyre-Mestre, Sandrine Andrieu, et al.. Persistent use of Analgesic Medications in Mild-to-Moderate Alzheimer's Disease.: Persistent analgesic use in Alzheimer's disease. Drugs and Aging, Adis, 2013, 30 (6), pp.439-45. <10.1007/s40266-013-0070-3>. <inserm-00812535>
  • Maryse Lapeyre-Mestre, Claudine Sapède, Nicholas Moore, Pascal Bilbault, Patrick Blin, et al.. Pharmacoepidemiology studies: what levels of evidence and how can they be reached?. Thérapie, EDP Sciences, 2013, 68 (4), pp.241-52. <10.2515/therapie/2013038>. <hal-01120370>
  • Philipe Barreto de Souto, Maryse Lapeyre-Mestre, Céline Mathieu, Christine Piau, Catherine Bouget, et al.. A multicentric individually-tailored controlled trial of education and professional support to nursing home staff: Research protocol and baseline data of the IQUARE study. Journal of Nutrition, Health and Aging, Springer Verlag (Germany), 2013, 17 (2), pp.173-178. <halshs-00847527>
  • Philippe Barreto de Souto, Céline Mathieu, Christine Piau, Maryse Lapeyre-Mestre, Catherine Bouget, et al.. Indicators of Benzodiazepine Use in Nursing Home Residents in France: A Cross-Sectional Study. Journal of the American Medical Directors Association, Elsevier, 2013, 14 (1), pp.29-33. <10.1016/j.jamda.2012.09.002>. <halshs-00847487>
  • Stephanie Berthet, Pascale Olivier, Jean-Louis Montastruc, Maryse Lapeyre-Mestre. Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database. BMC Clinical Pharmacology, BioMed Central, 2011, 11 (1), pp.5. <10.1186/1472-6904-11-5>. <inserm-00668416>
  • Mariam Molokhia, Atul Pathak, Maryse Lapeyre-Mestre, Laetitia Caturla, Jean Louis Montastruc, et al.. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France.. British Journal of Clinical Pharmacology, Wiley, 2008, 66 (3), pp.386-95. <10.1111/j.1365-2125.2008.03229.x>. <inserm-00409223>